Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FDSNL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,279
Award facts
- Contract value 100% obligated
- $21,278.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,278.76 to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Dupixent 300 mg/2 mL pen injectors. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999 and extending through December 2026. The delivery is scheduled for completion by October 21, 2025, with performance to take place at the company's corporate office in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp serves as a primary pharmaceutical distributor for federal military and veteran healthcare systems, leveraging its comprehensive IDC to supply an extensive range of medications and medical supplies across multiple therapeutic areas. As a major pharmaceutical distributor and healthcare solutions provider, the company fulfills critical medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. This delivery order exemplifies the company's ongoing role in supplying specialty medications to support military healthcare programs, with Dupixent being a brand-name biologic treatment for conditions including atopic dermatitis and eosinophilic asthma commonly used within military medical facilities.
Quick answers
Who was awarded contract SPE2DB26FDSNL?
SPE2DB26FDSNL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 20, 2025.
How much is contract SPE2DB26FDSNL worth?
The government has obligated $21,279 on SPE2DB26FDSNL.
Is contract SPE2DB26FDSNL an order under another contract?
Yes. SPE2DB26FDSNL is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB26FDSNL competed?
The extent of competition for SPE2DB26FDSNL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award